Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

BACKGROUND: The synthesis of CDK4/6 inhibitors with endocrine treatment in two series of treatment has been widely accepted as the standard for patients with estrogen receptor-positive metastatic breast cancer. In spite of this, the activity of CDK4/6 inhibitors in patients with metastatic breast ca...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Balkan Med J
Κύριοι συγγραφείς: Demir, Atakan, Mandel, Nil Molinas, Paydas, Semra, Demir, Gökhan, Er, Özlem, Turhal, Nazım Serdal, Bavbek, Sevil, Eralp, Yeşim, Saip, Pınar Mualla, Güler, Emine Nilüfer, Aydıner, Adnan, Oyan Uluç, Başak, Kılıçkap, Sadettin, Üskent, Necdet, Karadurmuş, Nuri, Kaplan, Mehmet Ali, Yanmaz, Mustafa Teoman, Demir, Hacer, Alan, Özkan, Korkmaz, Taner, Olgun, Polat, Sönmez Uysal, Özlem, Altundağ, Kadri, Gündüz, Şeyda, Günaldı, Meral, Sarı, Murat, Beypınar, İsmail, Başaran, Gül
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Galenos Publishing 2020
Θέματα:
Original Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7094190/
https://ncbi.nlm.nih.gov/pubmed/31970972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/balkanmedj.galenos.2020.2019.11.143
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια